Moderna
MRNA
#275
Rank
C$123.68 B
Marketcap
C$309.81
Share price
-0.47%
Change (1 day)
687.46%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total assets

Total assets on the balance sheet as of June 2026 : C$15.31 Billion

According to Moderna 's latest financial reports the company's total assets are C$15.31 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Moderna - Total assets on balance sheet (from 2017 to 2026)

Total assets by year

Year Total assets Change
2025-12-31C$16.89 B-16.74%
2024-12-31C$20.29 B-16.96%
2023-12-31C$24.43 B-30.35%
2022-12-31C$35.08 B11.61%
2021-12-31C$31.43 B236.06%
2020-12-31C$9.35 B350.66%
2019-12-31C$2.07 B-22.33%
2018-12-31C$2.67 B96.03%
2017-12-31C$1.36 B-28.41%
2016-12-31C$1.90 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
C$280.94 B 1,734.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$170.51 B 1,013.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$181.37 B 1,084.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
C$0.10 B-99.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
C$10.37 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$7.76 B-49.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$2.95 B-80.73%๐Ÿ‡บ๐Ÿ‡ธ USA